Einfach Bitcoin kaufen: Mit dem Code "FINANZEN" sparen Sie 21% der Gebühren für 6 Monate bei Coinfinity. Jetzt loslegen -w-
08.01.2019 22:14:00

Diagnostic Specialty Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

LONDON, Jan. 8, 2019 /PRNewswire/ -- Global Diagnostic Specialty Antibodies Market: Overview
Antibody is a blood protein produced in response to a specific antigen.An antibody is also known as immunoglobulin and is generally Y-shaped in structure.

Download the full report:

Advances in genetic engineering have made antibodies, especially monoclonal antibodies, more robust and efficacious as these increase the binding capacity to any type of specific antigen and are quite effective as a diagnostics tool to evaluate the various infectious diseases. However, demand for Diagnostic Specialty Antibodies is anticipated to decline during the forecast period owing to failure of antibodies in rapid diagnostic test for routine diagnosis and high cost of monoclonal antibodies.

The global diagnostic specialty antibodies market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on antibody type, application, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global diagnostic specialty antibodies market.

Global Diagnostic Specialty Antibodies Market: Key Segments
In terms of antibody type, the global diagnostic specialty antibodies market has been segmented into monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies.Based on application, the market has been classified into hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, infectious disease diagnostics, and others.

In terms of end-user, the global diagnostic specialty antibodies market has been categorized into hospitals, diagnostic laboratories, and others.The market has been analyzed based on price variations, technology trend, and presence of key players.

The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Diagnostic Specialty Antibodies Market: Regional Outlook
Geographically, the global diagnostic specialty antibodies market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and GCC Countries). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report
The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.Major companies profiled in the report are F.

Hoffmann-La Roche AG, Sanofi, Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc., among others.

The global diagnostic specialty antibodies market has been segmented as follows:

Global Diagnostic Specialty Antibodies Market, by Antibody Type
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies

Global Diagnostic Specialty Antibodies Market, by Application
Hepatitis Diagnosis
Tuberculosis Diagnostics
Dengue Diagnostics
Oncology Diagnostics
HIV Diagnostics
Infectious Disease Diagnostics
Others

Global Diagnostic Specialty Antibodies Market, by End-user
Hospitals
Diagnostic Laboratories
Others

Global Diagnostic Specialty Antibodies Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

Download the full report:

About
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email:
Tel: +1 (718) 213 4904
Website:

Cision View original content:

SOURCE ReportBuyer

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!